Assembly Biosciences, Inc. Available-for-sale Securities, Amortized Cost Basis
Assembly Biosciences, Inc. (ASMB) had Available-for-sale Securities, Amortized Cost Basis of $139.46 million as of 2019-06-30, per its 10-Q filed 2019-08-05.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2019-08-05
- 2019-06-30: Available-for-sale Securities, Amortized Cost Basis $139.46M.
- 2019-03-31: Available-for-sale Securities, Amortized Cost Basis $164.41M.
- 2018-12-31: Available-for-sale Securities, Amortized Cost Basis $176.74M.
- 2018-06-30: Available-for-sale Securities, Amortized Cost Basis $38.64M.
| Period end | Available-for-sale Securities, Amortized Cost Basis | Available-for-sale Securities, Amortized Cost Basis as first filed |
|---|---|---|
| 2019-06-30 | $139.46M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $164.41M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $176.74M 10-Q · filed 2019-08-05 | |
| 2018-06-30 | $38.64M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $42.49M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $41.45M 10-K · filed 2019-02-28 | $41.45M 10-K · filed 2018-03-08 |
| 2017-09-30 | $40.18M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $39.27M 10-Q · filed 2017-08-09 | |
| 2016-12-31 | $27.29M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $43.59M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $55.21M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $62.07M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $64.77M 10-K · filed 2017-03-02 | |
| 2015-09-30 | $60.97M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $48.78M 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |